|
Santa Cruz Biotechnology
p38 mapk inhibitor P38 Mapk Inhibitor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/p38+MAP+Kinase+Inhibitor+IX/pmc06939593-160-9-15 Average 93 stars, based on 1 article reviews
p38 mapk inhibitor - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
protein kinase inhibitor Protein Kinase Inhibitor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/p38+MAP+Kinase+Inhibitor/pmc04296919-76-12-19 Average 93 stars, based on 1 article reviews
protein kinase inhibitor - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
p38 inhibitor ![]() P38 Inhibitor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/p38+MAP+Kinase+Inhibitor+III/pm28983617-46-9-30 Average 90 stars, based on 1 article reviews
p38 inhibitor - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
m akt inhibitor viii ![]() M Akt Inhibitor Viii, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/p38+MAP+Kinase+Inhibitor+VIII/pmc03845241-53-14-18 Average 93 stars, based on 1 article reviews
m akt inhibitor viii - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Biosynth Carbosynth
p38 mapk inhibitor ![]() P38 Mapk Inhibitor, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/P38+MAP+Kinase+Inhibitor+IV/10__1074_slash_jbc__m609994200-51-12-8 Average 90 stars, based on 1 article reviews
p38 mapk inhibitor - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
p38 map kinase ![]() P38 Map Kinase, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/p38+MAP+Kinase+Inhibitor+V/pmc11058272-61-6-15 Average 93 stars, based on 1 article reviews
p38 map kinase - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Promega
sb202190 ![]() Sb202190, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/sb202190++inhibitor+of+p38+map+kinase+/pm16483932-158-20-24 Average 90 stars, based on 1 article reviews
sb202190 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Topivert Inc
inhibitors of p38 map kinase (particularly α and γ isoforms) and src kinase ![]() Inhibitors Of P38 Map Kinase (Particularly α And γ Isoforms) And Src Kinase, supplied by Topivert Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/inhibitors+of+p38+map+kinase++particularly+%CE%B1+and+%CE%B3+isoforms++and+src+kinase/10__3390_slash_molecules25153457-216-13-5 Average 90 stars, based on 1 article reviews
inhibitors of p38 map kinase (particularly α and γ isoforms) and src kinase - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Biomol GmbH
p38-alpha mapk inhibitors ![]() P38 Alpha Mapk Inhibitors, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/p38+%CE%B1+map+kinase+inhibitors/pm27765672-323-13-24 Average 90 stars, based on 1 article reviews
p38-alpha mapk inhibitors - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Promega
p38 map kinase inhibitor 4-(4-fluorophenyl)-2-(4-methylsulfinyl phenyl)-5-(4-pyridyl) 1h-imidazole ![]() P38 Map Kinase Inhibitor 4 (4 Fluorophenyl) 2 (4 Methylsulfinyl Phenyl) 5 (4 Pyridyl) 1h Imidazole, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/p38+map+kinase+inhibitor+4++4+fluorophenyl++2++4+methylsulfinyl+phenyl++5++4+pyridyl++1h+imidazole/pmc02857931-92-6-15 Average 90 stars, based on 1 article reviews
p38 map kinase inhibitor 4-(4-fluorophenyl)-2-(4-methylsulfinyl phenyl)-5-(4-pyridyl) 1h-imidazole - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Merck KGaA
xi-006 ![]() Xi 006, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p38+map+kinase+inhibitor+iii/p38+map+kinase+inhibitor+birb+796/pmc04476092-218-2-7 Average 90 stars, based on 1 article reviews
xi-006 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Molecular medicine reports
Article Title: CREB1 and Smad3 mediate TGF‑β3‑induced Smad7 expression in rat hepatic stellate cells.
doi: 10.3892/mmr.2017.7654
Figure Lengend Snippet: Figure 3. TGF‑β3 activates CREB1 via p38 to induce Smad7 expression. (A) HSCs were treated with the c‑Jun N‑terminal kinase inhibitor SP600125 (20 µM), the p38 inhibitor SB203580 (20 µM), the mitogen‑activated protein kinase kinase inhibitor PD98059 (20 µM), or the protein kinase A inhibitor H89 (5 µM) for 30 min, then treated with or without exogenous TGF‑β3 (10 ng/ml) for 2 h. Smad7 mRNA expression levels were assessed using reverse transcrip tion‑quantitative polymerase chain reaction. Control is defined as 1 (n=6). Data are expressed as the mean ± standard deviation. *P<0.05 compared to cells treated with exogenous TGF‑β3 in the control group. (B) HSCs were treated with the p38 inhibitor SB203580 (20 µM) for 30 min and then with or without exogenous TGF‑β3 (10 ng/ml) for 2 h. Protein expression levels of CREB1, p‑CREB1 and Smad7 were assessed using western blot analysis. Three independent experiments were performed and a representative blot is presented. TGF, transforming growth factor; CREB, cAMP responsive element binding protein; HSC, hepatic stellate cell; p‑, phosphorylated.
Article Snippet: SP600125, a c-Jun N-terminal kinase (JNK) inhibitor; SB203580, a
Techniques: Expressing, Polymerase Chain Reaction, Control, Standard Deviation, Western Blot, Binding Assay
Journal: International Journal of Endocrinology
Article Title: Effect of Gelam Honey on the Oxidative Stress-Induced Signaling Pathways in Pancreatic Hamster Cells
doi: 10.1155/2013/367312
Figure Lengend Snippet: Effect of quercetin and Gelam honey extract on pAkt (Ser473) expression.Quantitative analysis and representative western blot analysis of pAkt (Ser473) in HIT-T15 cells pretreated with quercetin and honey extract in cells cultured in 20 mM ((a), (c), (e)) and 50 mM ((b), (d), (f)) glucose. A sustained increase in the level of pAkt (ser473) was observed after pretreatment with quercetin and honey extract. Akt inhibitor VIII prevented the expression Akt ser473 phosphorylation induced by quercetin and honey extract. The results were normalized with β actin antibody. Data were presented as the mean ± standard deviation. (e) * P < 0.05; # P < 0.005 quercetin and honey extract treated compared to the 20 mM glucose alone. (f) * P < 0.05; # P < 0.005 quercetin and honey extract treated compared to the 50 mM glucose alone.
Article Snippet: To investigate inhibitory effects on Akt signaling pathway, cells were incubated with 5 μ
Techniques: Expressing, Western Blot, Cell Culture, Phospho-proteomics, Standard Deviation
Journal: International Journal of Endocrinology
Article Title: Effect of Gelam Honey on the Oxidative Stress-Induced Signaling Pathways in Pancreatic Hamster Cells
doi: 10.1155/2013/367312
Figure Lengend Snippet: The effect of flavonoids and Gelam honey extract on insulin content. (a) Effect of pretreatment with quercetin and Gelam honey extract and the addition of Akt inhibitor VIII on the insulin content in cells cultured in 20 mM glucose. There was a significant increase in insulin content (* P < 0.05) when the cells were pretreated with quercetin and honey. There was a significant decrease in insulin content (* P < 0.05) when the cells were treated with Akt inhibitor VIII, before pretreating with quercetin and Gelam honey extract. (b) Effect of pretreatment with quercetin and Gelam honey and the addition of Akt inhibitor VIII on the insulin content in cells cultured in 50 mM glucose. There was a significant increase in insulin content (* P < 0.05, # P < 0.005) when the cells were pretreated with quercetin and honey. There was a significant decrease in insulin content (* P < 0.05, # P < 0.005) when the cells were treated with Akt inhibitor VIII, before pretreating with quercetin and Gelam honey extract.
Article Snippet: To investigate inhibitory effects on Akt signaling pathway, cells were incubated with 5 μ
Techniques: Cell Culture
Journal: Experimental & Molecular Medicine
Article Title: The acute phase reactant orosomucoid-2 directly promotes rheumatoid inflammation
doi: 10.1038/s12276-024-01188-0
Figure Lengend Snippet: a Effect of NF-κB and p38 MAP kinase inhibitors on ORM2-stimulated IL6 and CXCL8 expression. RA-FLSs were pretreated with PDTC (10 μM), BAY 117082 (40 μM), or SB203580 (10 μM) for 1 h and then stimulated with recombinant ORM2 (1 μg/mL) for 6 h. IL6 and CXCL8 mRNA levels were assessed by qRT‒PCR. The data are presented as the mean ± SEM of more than three independent experiments. ** P < 0.01 and **** P < 0.0001 versus ORM2 according to the Kruskal–Wallis test ( IL6 : P < 0.0001, CXCL8 : P < 0.0001) with post hoc pairwise comparisons test using the Mann–Whitney U test. b Immunocytochemistry analysis of NF-κB p65 in RA-FLSs. Cells were activated with ORM2 (1 μg/mL) or LPS (100 ng/mL) for the indicated times. Representative confocal images of p65 translocation to the nucleus are presented. The extent of nuclear translocation (%) was manually counted and is presented in the bar graph. The data are presented as the mean ± SEM of more than three independent experiments. ** P < 0.01 and *** P < 0.001 versus no ORM2 according to two-way ANOVA ( P < 0.0001) with Sadik’s multiple comparisons. Scale bar: 20 μm. c Western blot analysis of IκB-α, NF-κB phospho-p65 ( p -p65), and NF-κB p65 in RA-FLSs stimulated with ORM2 for the indicated times (minutes [m]). d , e Decrease in ORM2-induced IL6 and CXCL8 mRNA levels induced by knockdown of NF-κB p65 . RA-FLSs were transfected with NF-κB p65 siRNAs (si-p65, 50 nM) or control siRNAs (si Con, 50 nM) for 24 h. NF-κB p65 expression was determined by qRT‒PCR (left in d ) and Western blot analysis (right in d ). IL6 and CXCL8 expression levels were determined by qRT‒PCR ( e ). f Total p38 and phospho-p38 ( p -p38) expression levels in RA-FLSs determined by Western blotting after stimulation with ORM2 for the indicated times (minutes). g Downregulation of p38 expression after 24 h of transfection with p38 siRNAs (si p38 , 50 nM), as determined by qRT‒PCR (left) and Western blot analysis (right). h qRT‒PCR analysis of IL6 and CXCL8 expression. i NF-κB p65 and p38 expression in double-knockdown cells was analyzed via qRT‒PCR. After p38 transcripts were knocked down for 24 h, RA-FLSs ( n = 6) were transfected again with si- p65 for an additional 24 h. j qRT‒PCR analysis of IL6 and CXCL8 expression. The qRT‒PCR data in ( e ), ( h ), and ( j ) were obtained for the siRNA-transfected RA-FLSs ( n = 5) 6 h after stimulation with ORM2 (1 μg/mL). The Western blot data in ( c ), ( d ), ( f ), and ( g ) are representative of three independent experiments. The bar graphs represent the mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001 according to the Mann‒Whitney U test for ( d ) and ( g ); one-way ANOVA ( IL6 in ( e ): P = 0.0003; IL6 in ( h ): P = 0.0004) with Tukey’s multiple comparisons test; Kruskal‒Wallis test ( CXCL8 in ( e ): P < 0.0001; CXCL8 in ( h ): P < 0.0001; p38 in ( i ): P = 0.0002; and IL6 in ( j ): P = 0.001) with post hoc pairwise comparisons test using a Mann‒Whitney U test; and Brown-Forsythe and Welch ANOVA ( P < 0.0001) with Dunnett T3 multiple-comparison test for CXCL8 in ( j ).
Article Snippet: Scrambled control siRNA and NF-κB p65,
Techniques: Expressing, Recombinant, MANN-WHITNEY, Immunocytochemistry, Translocation Assay, Western Blot, Knockdown, Transfection, Control, Comparison